Oak Ridge Investments LLC Dbv Technologies S.A. Transaction History

Oak Ridge Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$5.75 - $21.85 $1.48 Million - $5.62 Million	-257,109 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$16.81 - $24.58 $127,924 - $187,053	-7,610 Reduced 2.87%	257,109 $5.78 Million
Q2 2018 Aug 13, 2018	SELL	$18.6 - $24.94 $241,781 - $324,195	-12,999 Reduced 4.68%	264,719 $5.11 Million
Q1 2018 May 14, 2018	SELL	$20.86 - $26.6 $2.15 Million - $2.74 Million	-103,042 Reduced 27.06%	277,718 $6.41 Million
Q4 2017 Feb 13, 2018	SELL	$20.9 - $49.36 $4.42 Million - $10.4 Million	-211,346 Reduced 35.69%	380,760 $9.37 Million
Q3 2017 Nov 07, 2017	SELL	$39.62 - $46.17 $9.73 Million - $11.3 Million	-245,681 Reduced 29.32%	592,106 $25.1 Million
Q2 2017 Aug 10, 2017	BUY	N/A	837,787	837,787 $29.9 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.